Low-Endotoxin Protein Manufacturing Service

About Human Cell

Founded in 2015, Human Cell Corporation operates at the intersection of cell therapy and regenerative medicine, providing critical enabling tools for the broader industry. Its core offering is a suite of engineered cytokines that are long-acting and free of animal-derived components, which are essential for the expansion and differentiation of therapeutic cells like stem cells and immune cells. By also providing high-purity protein manufacturing services, the company supports both the research and development phases of biotech and pharma partners. Human Cell appears to be a private, platform-and-services company catering to the growing cell therapy manufacturing sector.